1-4 of 4
Eva De Smedt
Close
Sort by
Journal Articles

Histone Methyltransferases G9a and GLP; Identification and Validation of Novel Therapeutic Targets for Multiple Myeloma Treatment

Eva De Smedt, Julie Devin, Hui Liu, Anke Maes, Ken Maes, Kim De Veirman, Eline Menu, PhD, Karin Vanderkerken, PhD, Jerome Moreaux, PhD, Elke De Bruyne, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4356.
https://doi.org/10.1182/blood.V130.Suppl_1.4356.4356
Published: 2017
Journal Articles

The Anaphase Promoting Complex/Cyclosome: A New Promising Target in Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma

Anke Maes, Eva De Smedt, Kim De Veirman, Ken Maes, Eline Menu, PhD, Els Van Valckenborgh, PhD, Karin Vanderkerken, PhD, Elke De Bruyne, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2757.
https://doi.org/10.1182/blood.V130.Suppl_1.2757.2757
Published: 2017
Journal Articles

RAS Association Domain Family Member 4 (RASSF4): A New Potent Tumor Suppressor in Multiple Myeloma

Eva De Smedt, Ken Maes, PhD, Stefan Verhulst, Hui Lui, Alboukadel Kassambara, PhD, Anke Maes, Dirk Hose, MD, Karine Breckpot, Jerome Moreaux, PhD, Elke De Bruyne, PhD
Journal: Blood
Blood (2016) 128 (22): 2057.
https://doi.org/10.1182/blood.V128.22.2057.2057
Published: 2016
Journal Articles

The in vivo Transcriptional Response Towards Epigenetic Modulating Agents in Multiple Myeloma

Ken Maes, Eva De Smedt, Kassambara Alboukadel, PhD, Dirk Hose, MD PhD, Anja Seckinger, MD PhD, Els Van Valckenborgh, PhD, Eline Menu, PhD, Bernard Klein, MD PhD, Karin Vanderkerken, PhD, Jerome Moreaux, PhD, Elke De Bruyne, PhD
Journal: Blood
Blood (2014) 124 (21): 3375.
https://doi.org/10.1182/blood.V124.21.3375.3375
Published: 2014